T cells

Diabetes

Nanotherapy May Replace Daily Shots For Treating Type 1 Diabetes

UNIVERSITY NEWS — Individuals living with Type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence. Pancreatic islets control insulin production when blood sugar levels change, and in …

Nanotherapy May Replace Daily Shots For Treating Type 1 Diabetes Read More »

GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics

GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, announced it has closed on a Series A financing generating immediate proceeds of¬†$157 million. The fund raise was led by Matrix Capital Management with participation by Avidity Partners, JDRF T1D Fund, seed investors OrbiMed, RA Capital Management, and Novartis Venture Fund, …

GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics Read More »

immunotherapy researchers

New Type of Immunotherapy May Pave the Way for Better Cancer Treatments

Immunotherapy for cancer has made great advances and many patients can now receive effective treatments that were not available ten years ago. However, there are certain types of cancer that do not respond to existing immunotherapy. A study from Karolinska Institutet in Sweden published in Proceedings of the National Academy of Sciences (PNAS) reports on …

New Type of Immunotherapy May Pave the Way for Better Cancer Treatments Read More »